Bentham Science Logo

Track Your Manuscript:

Current Drug Targets

Volume 21, 16 Issues, 2020
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Authors' Comments

"We are highly satisfied with the services provided by Bentham Science.

The CDT staff was very friendly and gave prompt responses to our queries. We felt their service was excellent. Thank you very much."

Ammu Ajith
(Department of Chemistry, College of Arts and Sciences, Khalifa University, Abu Dhabi, United Arab Emirates)

"My publishing experience with “Current Drug Targets” is great. The editorial team was really professional and helpful throughout the entire editorial process. Their response to email query as well as the processing time of the manuscript, was excellent. The reviewers' and editor's comments are very helpful in improving the paper. Thank you for your cooperation in publishing our paper in the journal."

Rina Das
(M.M. College of Pharmacy, Maharishi Markandeshwar (Deemed to be University), Mullana, Ambala, HR, India)

"It was a nice experience to publish our article in current drug target. I felt that the journal is quick and has maintained very high standard by independently reviewing article from more than five reviewers. The communication between the author and the Journals editorial is also speedy. I hope the journal will continue to maintain and sustain its reputation"

Pushpender K. Sharma
(Department of Biotechnology, Sri Guru Granth Sahib World University, Fatehgarh Sahib, Pb, India)

"It was a great experience working with Bentham Science. We hope to work with Bentham Science in the future. "

Jaya Kumar
(Department of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia Medical Centre, 56000 Cheras, Kuala Lumpur, Malaysia)

"Thanks everybody. We are happy to get our paper published in your esteemed journal “current drug targets."

Hatta Sidi
(Department of Psychiatry, Faculty of Medicine, Universiti Kebangsaan, Kuala Lumpur, Malaysia)

"We are thankful to the Bentham Science Publishers and its Reviewers for careful review of the manuscript and providing us with the constructive criticism and suggestions which greatly improved the quality of the manuscript. The reviews were fair and prompt which made us analyze our work more deeply. The scientific standard is very high, and the publication process has been smooth, efficient and of high standard. The editorial staff has always been very co-operative and gave a prompt reply to the e-mail conversations during the entire review process. Finally, we appreciate all the insightful comments of Bentham Science Publishers."

Dr. Anjana Devi Tangutur
(CSIR-IICT - Centre For Chemical Biology Tarnaka-Hyderabad, Telangana, India)

"We would like to express our gratitude to Bentham Science Publishers for the wonderful experience while working with the journal on this mini-thematic issue. There are several reasons for this enthusiasm.

We are grateful to the Editor-in-Chief, Dr Francis J. Castellino, for contacting us and offering us the chance to publish in Current Drug Targets, and accepting our proposal for a mini-thematic issue. It was a wonderful experience working with Shabana Seemee at the time of submission and processing of the papers. Shabana was always ready to support us whenever we had either a problem or a query.

We would like to acknowledge the high standard of all others who took care of editing and processing the papers to obtain the best final quality at the time of publication.

We would be delighted to continue to collaborate with the journal."

Dr. Rodolfo Montironi
(Pathological Anatomy, Polytechnic, University of the Marche Region, School of Medicine, United Hospitals, Ancona, Italy)

"I really appreciate working with Bentham Science Publishers. It was a pleasure to collaborate with Ms. Shabana Seemee and Ms. Samina Khan, as they expressed a high level of professionalism. Moreover, their advices and suggestions concerning revision of the manuscript were clear and allowed fruitful assistance.

Our submission is likely to be of interest to the pharmaceutical and biomedical industry.

Furthermore, I have also forwarded free trial access to Bentham Science Journals’ offer to our librarians.

Thank you very much for cooperation."

Dr. Wojciech Miltyk
(Department of Pharmaceutical Analysis, Mickiewicza 2D, Bialystok, Poland)

"My experience with Bentham Science Publishers is extremely positive. The editorial staff is always very efficient, and has helped in a rapid accomplish of publication.

My publication could be of interest for many pharmaceutical companies which are working with Parkinsonian patients which are now with multi-morbidity.

Thank you again for giving us the possibility to work with you. "

Dr. Fulvio Lauretani
(Geriatric Unit, University Hospital of Parma, )

"It was my pleasure to contribute in one of the distinguished Bentham Science journals, “Current Drug Targets”. Regarding your service quality, I have only words of praise. Namely, speed, responsiveness, availability and compliance are the qualities that are synonymous with Bentham Science Publishers."

Zdravko Jotanovic
(Consultant Orthopaedic Surgeon University Hospital for Orthopaedics and Traumatology Lovran, Lovran, Croatia)


Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556

View Full Editorial Board

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 2.63


Covid Resource CenterCoronaviruses-JOIN-EDITORIAL-BOARD

Related Journals

Related eBooks

eBooks Catalog